CD4 and rheumatoid arthritis: Regarding the total, T, Th, and CD3+CD4− lymphocyte populations, a decrease in EGFR expression was observed in RA patients (6.44%, 5.73%, 5.62%, and 5.59%, respectively) with respect to HCs (31.20%; Figure 3A–D; Table S2).